Specifically targeting interleukin-13 with tralokinumab improved sleep in two phase III, randomized, double-blind, placebo-controlled trials in patients with atopic dermatitis

被引：0
|
作者：
Silverberg, J. I. [1 ]
Barbarot, S. [2 ]
Gooderham, M. [3 ]
Simon, J. C. [4 ]
Simpson, E. [5 ]
Kurbasic, A. [6 ]
Olsen, C. K. [6 ]
Cork, M. J. [7 ]
机构：
[1] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC 20052 USA
[2] CHU Nantes, Dept Dermatol, Nantes, France
[3] SKiN Ctr Dermatol, Peterborough, ON, Canada
[4] Univ Med Ctr, Dept Dermatol Venereol & Allergol, Leipzig, Germany
[5] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA
[6] LEO Pharma AS, Ballerup, Denmark
[7] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield Dermatol Res, Sheffield, S Yorkshire, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
342
引用
收藏
页码：E64 / E65
页数：2
相关论文
共 50 条
  • [41] Specific immunotherapy in the treatment of patients with atopic dermatitis - results of a double-blind, placebo-controlled study
    Silny, W.
    Czarnecka-Operacz, M.
    ALLERGOLOGIE, 2006, 29 (05) : 171 - +
  • [42] POLYPODIUM LEUCOTOMOS EXTRACT IN ATOPIC DERMATITIS: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND MULTICENTER CLINICAL TRIAL
    Ramirez-Bosca, A.
    Zapater Hernandez, P.
    Betlloch, I
    Albero, F.
    Martinez, A.
    De la Parte, Horga J. F.
    Diaz Alperi, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 : 28 - 28
  • [43] Montelukast treatment of moderate to severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled trial
    Veien, NK
    Busch-Sorensen, M
    Stausbol-Gron, B
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (01) : 147 - 149
  • [44] Blackcurrant seed oil for prevention of atopic dermatitis in newborns: a randomized, double-blind, placebo-controlled trial
    Linnamaa, P.
    Savolainen, J.
    Koulu, L.
    Tuomasjukka, S.
    Kallio, H.
    Yang, B.
    Vahlberg, T.
    Tahvonen, R.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2010, 40 (08): : 1247 - 1255
  • [45] Lansoprazole in the treatment of functional dyspepsia: Two double-blind, randomized, placebo-controlled trials
    Peura, DA
    Kovacs, TOG
    Metz, DC
    Siepman, N
    Pilmer, BL
    Talley, NJ
    AMERICAN JOURNAL OF MEDICINE, 2004, 116 (11): : 740 - 748
  • [46] Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial
    Langer, Sarah Sella
    Cardili, Renata Nahas
    Lima Melo, Janaina Michelle
    Leme Ferriani, Mariana Paes
    Moreno, Adriana Santos
    Dias, Marina Mendonca
    Bueno-Filho, Roberto
    Candido Pocente, Renata Helena
    Roxo-Junior, Persio
    Silva, Jorgete
    Pereira Valera, Fabiana Cardoso
    Coelho, Eduardo Barbosa
    Santos Galvao, Clovis Eduardo
    Carmona, Fabio
    Aragon, Davi Casale
    Arruda, Luisa Karla
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (02): : 539 - +
  • [47] Esomeprazole Treatment of Frequent Heartburn: Two Randomized, Double-Blind, Placebo-Controlled Trials
    Peura, David A.
    Traxler, Barry
    Kocun, Christopher
    Lind, Tore
    POSTGRADUATE MEDICINE, 2014, 126 (04) : 33 - 41
  • [48] Antithrombin III in patients with severe sepsisA randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis
    B. Eisele
    H. Heinrichs
    U. Delvos
    M. Lamy
    L. G. Thijs
    H. O. Keinecke
    H. P. Schuster
    F. R. Matthias
    F. Fourrier
    Intensive Care Medicine, 1998, 24 : 663 - 672
  • [49] Antithrombin III in patients with severe sepsis - A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis
    Eisele, B
    Lamy, M
    Thijs, LG
    Keinecke, HO
    Schuster, HP
    Matthias, FR
    Fourrier, F
    Heinrichs, H
    Delvos, U
    INTENSIVE CARE MEDICINE, 1998, 24 (07) : 663 - 672
  • [50] The CAPACITY (CAP) Trials: Randomized, Double-Blind, Placebo-Controlled, Phase III Trials of Pirfenidone (PFD) in Patients with Idiopathic Pulmonary Fibrosis (IPF)
    Noble, P.
    Albera, C.
    Bradford, W.
    Costabel, U.
    Kardatzke, D.
    King, T., Jr.
    Sahn, S.
    Szwarcberg, J.
    Valeyre, D.
    du Bois, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345